359 filings
Page 5 of 18
8-K
bwtj tq67d36o
20 Jun 23
Other Events
6:06am
424B3
xmat4bodl
8 Jun 23
Prospectus supplement
6:14am
8-K
cljnwrruv
8 Jun 23
Entry into a Material Definitive Agreement
6:11am
424B5
xo8ntxqli7w9
8 Jun 23
Prospectus supplement for primary offering
6:06am
424B3
m7wm47pp5
30 May 23
Prospectus supplement
4:29pm
8-K
95t4o1913ao
30 May 23
Entry into a Material Definitive Agreement
4:24pm
424B5
htrg4bj3vmnlwqn
30 May 23
Prospectus supplement for primary offering
4:18pm
424B3
74ozeywp
25 May 23
Prospectus supplement
5:06pm
8-K
7wqhk4yl923ugk
25 May 23
Other Events
5:01pm
424B3
zy9p6zvfz7c8 78
19 May 23
Prospectus supplement
5:20pm
8-K
sqiaiinew8 qa8kghu5
19 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
4
xjoy3t5gjcqoageiivl
16 May 23
eFFECTOR Therapeutics / STEPHEN T WORLAND ownership change
8:03am
4
it35qf6vyk7gxz7n1fb
16 May 23
eFFECTOR Therapeutics / Michael Byrnes ownership change
8:01am
ARS
63ucdlhaf0uua5m99wl3
12 May 23
Annual report to shareholders
4:23pm
DEFA14A
h3r1ywhu
12 May 23
Additional proxy soliciting materials
4:17pm
424B3
8z4zmk838 jr
9 May 23
Prospectus supplement
4:30pm
8-K
8afp69
9 May 23
2023 Financial Results and Provides Corporate Update
4:18pm